Covid global health emergency is over, WHO says
Close to 20 million people are likely to have died during the last three years, says the WHO.
Similar Posts
6 All-Terrain Shoes That Actual Hikers Wear
Summer is a glorious time for people who enjoy hiking, as it’s a low-impact workout you can do while also exploring the outdoors. Aside from the health benefits of the activity (like core strengthening, a lower risk of heart disease, and balance improvement), for many hikers, it provides a much-needed mood boost. Logan Reavis, an…
Catalent’s Indiana plant to make Novo’s Wegovy weight-loss drug | Reuters News Agency
Health 25 August 2023, 6:39 pm 1 minute Reuters exclusively reported that Novo Nordisk has hired Thermo Fisher as its second contract manufacturer for its hugely popular weight-loss drug Wegovy. Novo Chief Financial Officer Karsten Munk Knudsen told Reuters in May the company had signed up a second contract manufacturer in the United States, but…
Drew Barrymore Had A Perimenopausal Hot Flash On Live TV While Interviewing Jennifer Aniston & Adam Sandler
“I don’t know that I have ever heard a celebrity talk about a hot flash in the moment. Thank you for being so real.” View Entire Post ›
Junior doctors’ strike: NHS chief warns of tough new year
A planned six-day junior doctors’ strike will have a big impact on routine care, a health chief says.
New reason to skip alcohol, changing weight loss goals, and what smoking does to the brain
As weight-loss medications like Ozempic and Wegovy peak in popularity moving into the New Year, semaglutide experts believe these meds could make it more likely that people will stick with their resolutions. (SEBASTIEN BOZON/AFP via Getty Images) STICKING WITH IT – Ozempic and other weight-loss drugs may strengthen New Year’s resolutions, experts say. Continue reading……
Moderna stock pops after Oppenheimer says Covid shot maker could launch more products over next two years
Artur Widak | Nurphoto | Getty Images Shares of Moderna closed more than 13% higher on Tuesday after Oppenheimer upgraded the stock to “outperform,” saying the Covid vaccine maker could market five products by 2026. The upgrade follows a dismal 2023 for Moderna, whose only commercially available product is its Covid shot. The company’s stock…
